about
ELOVL5 mutations cause spinocerebellar ataxia 38Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.Autistic-Like Traits and Cerebellar Dysfunction in Purkinje Cell PTEN Knock-Out MiceMouse brain expression patterns of Spg7, Afg3l1, and Afg3l2 transcripts, encoding for the mitochondrial m-AAA protease.Excitability and synaptic alterations in the cerebellum of APP/PS1 miceEarly enriched environment exposure protects spatial memory and accelerates amyloid plaque formation in APP(Swe)/PS1(L166P) mice.Genetic Deletion and Pharmacological Inhibition of PI3K γ Reduces Neutrophilic Airway Inflammation and Lung Damage in Mice with Cystic Fibrosis-Like Lung Disease.Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia.Parallel fiber to Purkinje cell synaptic impairment in a mouse model of spinocerebellar ataxia type 27.Motor dysfunction and cerebellar Purkinje cell firing impairment in Ebf2 null mice.Motor Deficits and Cerebellar Atrophy in Elovl5 Knock Out Mice.Selection of reference genes for quantitative real-time RT-PCR studies in mouse brain.The 5-HT7 receptor triggers cerebellar long-term synaptic depression via PKC-MAPK.Maturation, Refinement, and Serotonergic Modulation of Cerebellar Cortical Circuits in Normal Development and in Murine Models of Autism.Noradrenergic modulation of the parallel fiber-Purkinje cell synapse in mouse cerebellum.Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease.Purkinje Cell Signaling Deficits in Animal Models of Ataxia.Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicityThe Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer's DiseaseSox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann gliaEmerging roles of Fgf14 in behavioral control
P50
Q24301387-2D03B1D4-663F-4E5C-B603-3092F3D7F312Q28069538-11649DB8-6F48-41B2-BE9B-00781DD93C8AQ30742805-0A818DDA-A88F-48CC-BF5A-14F5076147D2Q33567198-1F9E4BC1-9D5C-496B-A9DF-C584EBA9187EQ34236857-9C9914DF-8024-4716-AB9C-9D05CE9553D5Q37042867-BD73F344-D330-40C8-95C1-E9DBDC604F71Q41431296-988827D2-7EBD-4206-9272-560DCEA2955CQ41501850-A38D9DC0-4A1F-475A-A7D1-0D50160639EDQ42055747-C854B2E5-72F2-4D5A-9365-E8CED1EF173DQ43966724-23E0EED5-6A29-463B-B038-EC5611B41478Q46210941-EB6FDA77-A595-4549-BDEE-85B5B29AC852Q46943029-97B9A26C-3137-46C8-9241-226B2B1D11BAQ48072262-5FE99C32-C10E-4872-97F5-AD258659306BQ48089818-82AEA5DA-F84A-4049-B9E3-7B085C847362Q48214009-482DE0FA-2DE0-47C9-BD41-A119C2E2B65AQ48902964-D4A64307-C424-4FEB-9877-AD7777271C5BQ55097137-49D414F4-21D4-41FC-867A-F6E13BA89EC5Q58594194-BCFDFC0D-D4AE-49FA-8629-1867AF6AA9FCQ59806753-77AAA0F3-13DE-4684-B309-CAA05E515C25Q88585708-2C6BEC46-DBC5-469A-BC66-766616C9DCEBQ91317714-04E90BDA-BA39-4F14-A2AA-32739D9950DD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eriola Hoxha
@ast
Eriola Hoxha
@en
Eriola Hoxha
@es
Eriola Hoxha
@nl
Eriola Hoxha
@sl
type
label
Eriola Hoxha
@ast
Eriola Hoxha
@en
Eriola Hoxha
@es
Eriola Hoxha
@nl
Eriola Hoxha
@sl
prefLabel
Eriola Hoxha
@ast
Eriola Hoxha
@en
Eriola Hoxha
@es
Eriola Hoxha
@nl
Eriola Hoxha
@sl
P1053
N-1752-2017
P106
P1153
24449402600
P2798
P31
P3829
P3835
eriola-hoxha
P496
0000-0002-4452-889X